C/Can and IQN Path Unite to Advance Access to Quality Biomarker Testing in LMICs
Precision oncology is reshaping what is possible in cancer care. By aligning treatment with a patient’s individual biomarkers it offers the potential for more effective and timely care. Yet progress is uneven. While high-income countries (HICs) are rapidly expanding access to these innovations, many low- and middle-income countries (LMICs) continue to face fundamental constraints, including…
